Strober , B., A. Asahina, U. Mrowietz, M. Lebwohl, P. Foley, R. Langley, J. Barker, C. Cioffi, N. Cross, M. . Wang, and C. Paul. “Bimekizumab Response Maintenance through Two Years of Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Responded After 16 Weeks: Interim Results from the BE BRIGHT Open-Label Extension Trial”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s52, doi:10.25251/skin.5.supp.52.